How should investors evaluate Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA)?

Stocks of Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) traded higher last session on Wall Street, down -1.53% to $16.74. TEVA stock price is now -14.35% away from the 50-day moving average and -6.20% away from the 200-day moving average. The market capitalization of the company currently stands at $19.18B. With the price target maintained at […]

How should investors evaluate Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA)?

Stocks of Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) traded higher last session on Wall Street, down -0.50% to $21.68. TEVA stock price is now 12.11% away from the 50-day moving average and 24.15% away from the 200-day moving average. The market capitalization of the company currently stands at $24.60B. With the price target maintained at […]

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.